COVID-19

News

US court halts Biden's COVID shots plan for companies

The US Federal Court of Appeals has issued a temporary stay on President Joe Biden's plan for mandatory COVID-19 vaccinations for employees of businesses.

News

Pfizer's pill cuts COVID deaths and hospitalisations by 90%

An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or death from COVID-19 when given in the early stages of infection.

News

UK first to authorise Merck/Ridgeback's COVID pill molnupira...

Merck & Co and Ridgeback's oral antiviral molnupiravir has been approved in its first market – the UK – as a treatment for people with mild to moderate COVID-19 who are at increased ris

News

US backs COVID jabs for young kids – should others follow?

The US is now pressing ahead with plans to extend its COVID-19 vaccination campaign to younger children aged five and over, prompting a debate about the policy in other countries.<

News

scientifically visualization of a coronavirus spike protein

COVID jabs much more effective than virus at preventing infe...

A US study has found that the immunity afforded by COVID-19 vaccines is much stronger than that stimulated by infection with SARS-CoV-2 in unvaccinated individuals.

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Pfizer's COVID jab sales swell again, with $36bn forecast fo...

Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once again to a whopping $36 billion, more than double its predictions just a

US court halts Biden's COVID shots plan for companies

Pfizer's pill cuts COVID deaths and hospitalisations by 90%

UK first to authorise Merck/Ridgeback's COVID pill molnupira...

US backs COVID jabs for young kids – should others follow?

COVID jabs much more effective than virus at preventing infe...

Pfizer's COVID jab sales swell again, with $36bn forecast fo...

NICE guidance calls for quicker diagnosis of PMOS

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks